The increased degradation stimulated by proteolytic and pro-oxidative hyperactivity in children with JIA might be not compensated for by the intensity of biosynthesis of ECM compounds, which involves an insulin-like growth factor 1 (IGF-1). This evidence concerns the gene IGF1 and juvenile idiopathic arthritis.